Month: November 2016

Erika Kelton in The Mercury News, 11/4/16. “The FDA rules and regulations for marketing a prescription drug or device are there for a very good reason: to protect the public,” said Erika Kelton, a...

SAN FRANCISCO, CALIFORNIA, November 4, 2016 – The third edition of an important legal treatise on the False Claims Act by Phillips & Cohen partner Claire M. Sylvia has just been published by...

Sean McKessy in Ignites (Financial Times), 11/1/16. The SEC’s recent amicus brief is the second that it has filed in the case on the issue of whistle-blower status. The agency also filed an amicus brief...

WASHINGTON, DC, November 1, 2016 – US News & World Report has listed Phillips & Cohen in its 2017 rankings of “Best Law Firms.” Phillips & Cohen is the longest-standing and...

The False Claims Act, along with its “qui tam” whistleblower provision, has emerged as the government’s best tool to combat fraud committed by for-profit colleges. The law has helped recover millions...